Skip to main content
    M

    MDxHealth SA (MDXH)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $0.15
    +0.00 (+3.40%)

    Market Cap: $13.75M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    MDxHealth SA (MDXH) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect MDxHealth SA (MDXH) to earn -$0.46 per share in the fiscal year ending Dec 31, 2026, on revenue of $96.75M. Of 6 analysts, 1 rates the stock Buy or Strong Buy, 5 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 2.83, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 17% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy116.7%
    Hold583.3%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    6

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 12.2%.

    Fiscal year ending Dec 31, 2026
    -$0.46
    EPS consensus, revenue $96.75M
    Fiscal year ending Dec 31, 2027
    -$0.38
    EPS consensus, revenue $108.60M

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.46-$0.46 to -$0.461$96.75M$87.08M to $100.69M6
    Dec 31, 2027-$0.38-$0.38 to -$0.381$108.60M$90.52M to $115.46M6

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.09-$0.11 to -$0.077$26.38M$22.05M to $32.66M7

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202701

    EPS Trend

    The EPS consensus for the fiscal year ending Dec 31, 2026 has held over the last 90 days.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.46-$0.46-$0.46-$0.46-$0.46N/A
    Fiscal year ending Dec 31, 2027-$0.38-$0.38-$0.38-$0.38-$0.38N/A

    Frequently Asked Questions About MDXH

    What is the MDXH stock forecast?

    Consensus analyst estimates put MDxHealth SA's EPS at -$0.46 for the fiscal year ending Dec 31, 2026, on revenue of $96.75M. The consensus rating from 6 analysts is Hold.

    How do analysts rate MDXH stock?

    Of 6 analysts covering MDxHealth SA, 0 rate it Strong Buy, 1 Buy, 5 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from MDXH next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.46, with estimates from -$0.46 to -$0.46 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.38, with estimates from -$0.38 to -$0.38 from 1 analyst.

    What revenue do analysts expect from MDxHealth SA next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $96.75M, with estimates from $87.08M to $100.69M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $108.60M, with estimates from $90.52M to $115.46M.

    How many analysts cover MDXH?

    6 analysts rate MDxHealth SA stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.